FDA Warning Letters for Misbranding Cannabinoid Products as Dietary Supplement on the Rise – Bella Rose Labs
0
By
In Dietary Supplements (Claims and Labeling)
Posted

FDA Warning Letters for Misbranding Cannabinoid Products as Dietary Supplement on the Rise – Bella Rose Labs

FDA issues warning letter to New York manufacturer for CBD claims that indicates its products are new drugs and do not qualify as dietary supplements

READ MORE
 Red Flags that Leads to FDA Warning Letters
0
By
In FDA & FTC Law
Posted

Red Flags that Leads to FDA Warning Letters

The FDA issues warning letters for numerous products including dietary supplements. FDA violations include findings that the supplement is a new drug, product adulteration, misbranding, and [...]

READ MORE